GlaxoSmithKline (GSK) was formed through the merger of two companies: Glaxo Wellcome and SmithKline Beecham. Glaxo Wellcome traces its origins back to the establishment of Glaxo in 1904 by Joseph Nathan, while SmithKline Beecham was formed from the merger of SmithKline & French and Beecham Group in the late 20th century. Thus, there isn't a single founder of GSK, but rather a combination of founders from its predecessor companies.
The population of GlaxoSmithKline is 2,010.
GlaxoSmithKline was created in 2000.
Glaxosmithkline is actually a company that specializes in global pharmaceuticals, biologics, vaccines, and consumer healthcare. Glaxosmithkline has its headquarters in London, England.
The symbol for GlaxoSmithKline PLC in the NYSE is: GSK.
GlaxoSmithKline Pharmaceuticals Ltd's population is 3,500.
GlaxoSmithKline Pharmaceuticals Ltd was created in 1924.
GlaxoSmithKline, 2000-, chief executive officer.
GlaxoSmithKline
As of July 2014, the market cap for GlaxoSmithKline PLC (GSK) is $121,563,516,721.28.
The largest pharmaceutical company in Great Britain is GlaxoSmithKline plc. GlaxoSmithKline is the fourth largest pharmaceutical company in the world.
The ticker symbol is GSK
GSK stands for GlaxoSmithKline pharmaceuticals.